Australia markets closed

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (300452.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
13.16-0.07 (-0.53%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 3.09B
Enterprise value 2.78B
Trailing P/E 30.83
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.69
Price/book (mrq)4.73
Enterprise value/revenue 4.14
Enterprise value/EBITDA 18.84

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 325.06%
S&P500 52-week change 3-16.62%
52-week high 321.53
52-week low 39.68
50-day moving average 313.78
200-day moving average 313.80

Share statistics

Avg vol (3-month) 38.58M
Avg vol (10-day) 33.38M
Shares outstanding 5234.52M
Implied shares outstanding 6N/A
Float 8105.11M
% held by insiders 144.47%
% held by institutions 12.35%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.3
Forward annual dividend yield 42.28%
Trailing annual dividend rate 30.23
Trailing annual dividend yield 31.75%
5-year average dividend yield 41.19
Payout ratio 470.27%
Dividend date 3N/A
Ex-dividend date 426 May 2022
Last split factor 21:1
Last split date 326 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 June 2022

Profitability

Profit margin 15.22%
Operating margin (ttm)15.44%

Management effectiveness

Return on assets (ttm)6.78%
Return on equity (ttm)14.34%

Income statement

Revenue (ttm)671.16M
Revenue per share (ttm)2.81
Quarterly revenue growth (yoy)26.70%
Gross profit (ttm)178.18M
EBITDA 139.79M
Net income avi to common (ttm)102.15M
Diluted EPS (ttm)0.43
Quarterly earnings growth (yoy)45.90%

Balance sheet

Total cash (mrq)336.48M
Total cash per share (mrq)1.4
Total debt (mrq)31.4M
Total debt/equity (mrq)4.38
Current ratio (mrq)2.20
Book value per share (mrq)2.70

Cash flow statement

Operating cash flow (ttm)126.28M
Levered free cash flow (ttm)100.23M